Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin family member 5A (KIF5A) is a motor protein belonging to the kinesin superfamily, characterized by its role in ATP-dependent intracellular transport along microtubules, primarily within neurons. KIF5A is crucial for anterograde (forward) transport of organelles, proteins, and RNAs in axons and dendrites, supporting neuronal survival and function. Structurally, it contains an N-terminal motor domain responsible for microtubule binding and movement, a central coiled-coil stalk for dimerization, and a C-terminal domain for cargo binding. Mutations in the KIF5A gene are linked to hereditary spastic paraplegia 10, amyotrophic lateral sclerosis (ALS), and Charcot-Marie-Tooth disease, reflecting its importance in neuronal health and axonal transport. KIF5A dysfunction can lead to the accumulation of mislocalized proteins and organelles, contributing to neurodegeneration. Emerging small molecule inhibitors, such as epigallocatechin gallate, have been computationally explored for disease intervention by disrupting aberrant mutated KIF5A activity.
Inhibition of microtubule motor activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family member 5A (KIF5A).